First HPV Test for Primary Cervical Cancer Approved

April 24, 2014 9:28 PM

7 0

First HPV Test for Primary Cervical Cancer Approved

The FDA has approved Roche's cobas HPV Test, the first human papillomavirus (HPV) DNA test for women ages >25 that can be used alone to help assess the need for additional diagnostic testing for cervical cancer. This test also can provide information about the patient's risk for developing cervical cancer in the future.

The cobas HPV Test was initially approved in 2011 for use in conjunction with or as follow-up to a Pap test. The FDA approval now expands use of the test as either a co-test or as a primary cervical cancer screening test.

Read more

To category page

Loading...